The largest database of trusted experimental protocols

10 protocols using mcf 7

1

Culturing Tamoxifen-Resistant Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF7, T47D and HEK293T cells were obtained from the American Type Culture Collection (ATCC). MCF7, Tamoxifen-resistant MCF7 and HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; 01-052-1ACS, Biological Industries) supplemented with 10% fetal bovine serum (FBS; 04-001-1ACS, Biological Industries), and T47D cells were cultured in RPMI 1640 medium (01-100-1ACS, Biological Industries) supplemented with 10% FBS. Tamoxifen-resistant MCF7 cells were developed by culturing MCF7 cells in the presence of 2 μM Tamoxifen (HY-13757A, MedChemExpress) for >12 months. Tamoxifen-resistant MCF7 cells were then maintained in the presence of 1 μM Tamoxifen. All cells were cultured in a humidified incubator with 5% CO2 at 37°C. If estrogen (E2, E8875, Sigma) was added, cells were maintained in stripping medium (phenol red free) plus 5% charcoal-depleted FBS for 72 h before treatment.
+ Open protocol
+ Expand
2

Developing Tamoxifen-Resistant Breast Cancer Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 breast cancer cells were obtained from the American Type Culture Collection and cultured as previously described (10 (link)). Briefly, MCF-7 cells were cultured in RPMI-1640 supplemented with 10% FBS (Biological Industries), 100 U/ml penicillin, 100 µg/ml streptomycin and 20 mM L-glutamine (Invitrogen; Thermo Fisher Scientific, Inc.). TAM-resistant MCF-7 cells were developed by the treatment of wild-type MCF-7 cells with 1x10-6 M 4-hydroxytamoxifen (Sigma-Aldrich; Merck KGaA) for 21 days and then 1x10-7 M 4-hydroxytamoxifen for 6 months, as described previously (15 (link)). All cells were maintained in a humidified incubator with 5% CO2 at 37˚C. In the present study, 4-hydroxytamoxifen was used as it is the main active metabolite of TAM. These 4-hydroxytamoxifen-treated cells were named as MCF-7R and the corresponding parental cells as MCF-7.
+ Open protocol
+ Expand
3

TNBC and Non-TNBC Cell Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hs-578T (TNBC cells with mutant-type p53) and MCF-7 (non-TNBC cells with wild-type p53) were 10% fetal bovine serum cultivated in Dulbecco’s Modified Eagle’s medium (Biological Industries, USA) from the Type Culture Set of the Chinese Academy of Sciences (Shanghai, China). DU4475 (TNBC cells with wild-type p53) were 10% fetal bovine serum cultivated in 1640 medium (Biological Industries, USA) from the FuHeng BioLogy (Shanghai, China). Under normal incubator conditions (37°C and 5% carbon dioxide), all cells were developed. THZ1 (HY-80013) and LDC4297 (HY-126p53) were obtained from MedChemExpress (Monmouth Junction, NJ, USA). All drugs we used in this article were dissolved in a stock solution of 10 mM dimethyl sulfoxide (DMSO).
+ Open protocol
+ Expand
4

Culturing Human Breast Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines BT549, MDA-MB-231, MCF7, and SKBR3 were purchased from ATCC. BT549 were cultured in 1640 medium (Biological Industries, Cromwell, USA). MDA-MB-231 were cultured in Leibovitz's L15 medium (Thermo Fisher Scientific, Carlsbad, USA). MCF7 were cultured in DMEM medium (Biological Industries, Cromwell, USA). SKBR3 were cultured in 5A medium (Biological Industries, Cromwell, USA). All these cells were incubated at an atmosphere of 37°C and 5% CO2.
+ Open protocol
+ Expand
5

Culturing Cancer Cell Lines and Controls

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were grown under standard growth conditions. The following cells were used: Jurkat (T cell leukemia), MCF-7 (breast adenocarcinoma), U266 (multiple myeloma), MEL (melanoma), JeKo-1 (mantle cell lymphoma), A549 (lung carcinoma). Human mononuclear cells (MNCs) from healthy volunteers and human fibroblasts served as a negative control. All cell lines were originated from the American Type Culture Collection (ATCC). U-266, Jurkat, JeKo-1 and MEL were cultured in RPMI-1640, A549 and MCF-7 in DMEM supplemented with 10–20% fetal bovine serum (FBS), 100 units/mL L-glutamine and 1% penicillin/streptomycin/nystatin (Biological Industries Beit Haemek, Israel) at 37 °C with 5% CO2. Jurkat and MEL cell media were supplemented with 10% FBS, U-266 was grown in the presence of 15% FBS and JeKo-1 with 20% FBS. Fibroblasts were propagated in DMEM with 20% FBS supplemented with L-glutamine and penicillin/streptomycin/nystatin.
Patients’ samples were obtained upon consent via protocol # 0038-12 approved by the IRB of Rabin Medical Center.
+ Open protocol
+ Expand
6

Breast Cancer Tissue Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Formaldehyde-fixed paraffin-embedded (FFPE) BC tissues and unpaired mammary hyperplasia (non-tumor tissues) were randomly collected from patients who had undergone surgery at the Shaanxi Provincial People's Hospital in China. Clinicopathological data such as age and gender, as well as histological data, tumor size, lymph node metastasis status, ER status, PR status, and AR status were obtained by reviewing their pathology records. Specimens were collected after obtaining written informed consent from the patients as well as approval of the ethical committees. Patient anonymity was maintained throughout the study. Human BC cell lines MCF-7, HCC1937, MDA-MB-231 and MDA-MB-435, human breast epithelium cells HBL-100 [23 (link)] and human embryonic kidney (HEK) 293T cells were obtained from the Cell Bank (Shanghai Institute of Biochemistry and Cell Biology, CAS, Shanghai, China).Cells were maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (Biological Industries) and 1% antibiotics (100 U/mL penicillin and 100 mg/mL streptomycin sulfate). Cells were grown in 5% CO2 at 37 °C. The cell line was tested for mycoplasma contamination using the Mycoplasma Detection Kit (Beyotime, Haimen, China) and was found to be negative.
+ Open protocol
+ Expand
7

Cell Line Cultivation and Compound Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF10A, HCC1937, MDA‐MB‐231, MCF7, T47D, BT474, and SKBR3 cell lines were purchased from the ATCC. The HCC1937, MDA‐MB‐231, MCF7, T47D, BT474, and SKBR3 cell lines were maintained in Dulbecco's modified Eagle's medium (DMEM, 06‐1055‐57‐1ACS; Biological Industries) with 10% fetal bovine serum (FBS, 04‐001‐1ACS; Biological Industries) and 100 U/mL penicillin–streptomycin. MCF10A cells were maintained in DMEM/F12 (1:1) containing 5% horse serum, 0.5 μg/mL hydrocortisone, 10 μg/mL insulin, 20 ng/mL EGF, 0.1 μg/mL cholera toxin, and 100 U/mL penicillin–streptomycin. The MDA‐MB‐231 cells were treated with SGC707 (MCE, HY‐19715) at concentrations of 4 and 8 μmol/L.
+ Open protocol
+ Expand
8

Breast Cancer Cell Line Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human breast cancer MDA-MB-231, MCF-7 and SK-BR-3 cell lines, and the human mammary epithelial MCF-10A cell line, were purchased from the Shanghai Institute of Biochemistry and Cell Biology. MDA-MB-231 and MCF-7 cells were cultured in complete DMEM supplemented with 10% FBS (both Biological Industries), 100 U/ml penicillin and 100 µg/ml streptomycin. SK-BR-3 and MCF-10A cells were cultured in RPMI-1640 (Biological Industries) containing 1.5 mg/ml NaHCO3, 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. All cell lines were cultured at 37°C in a 5% CO2 atmosphere.
Short hairpin RNA (shRNA) targeting AQP1 mRNA (sh-AQP1; 5′-CCATTATGCTGGTGTATGT-3′) (GV248-AQP1) and the corresponding negative control shRNA with a non-targeting AQP1 sequence (sh-NC; 5′-TTCTCCGAACGTGTCACGT-3′) (GV248-NC) were designed and synthesized by Shanghai GeneChem Co., Ltd., and the concentrations were both adjusted to 1×108 TU/ml. The sh-AQP1 and sh-NC (MOI=20) were transfected into MDA-MB-231 cells (3.0×103 cells per well) using polybrene (Beyotime Institute of Biotechnology) according to the manufacturer's protocol. The duration of transfection was 12 h at 37°C followed by changing the fresh medium. Transfected cells were used for subsequent experiments after 72 h.
+ Open protocol
+ Expand
9

Cell Culture and Seeding on Micropatterns

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines were obtained from commercial suppliers (MCF7, ATCC® HTB-22 and MDA MD 231, ATCC® CRM-HTB-26). MCF7 cells were cultured in DMEM low glucose (Biological Industries, Beit-Haemek, Israel) supplemented with 10% FBS, 100 U/mL1 penicillin, and 100 μg/mL1 streptomycin. MDAMB231 cells were cultured in DMEM (Biological Industries, Beit-Haemek, Israel) supplemented with 10% FBS, 100 U/mL1 penicillin, and 100 μg/mL1 streptomycin. Cells were grown in cell culture flasks until 90% confluency and detached using 0.05% Trypsin EDTA (Biological Industries, Israel). The cell suspension is counted and seeded on the micropatterns with a density of 5 × 104 cells/mL1 (5 × 104 cells/well), and the chips were cultured in a Petri dish at 37 °C, 5% CO2. For controls, the same number of cells was seeded into 24-well plates.
+ Open protocol
+ Expand
10

Cell Lines for Breast Cancer Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human breast cancer cell lines (MDA-MB-231 and MCF-7) and human normal mammary epithelial cell line MCF-10A were purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). B3GALT4-overexpressed or -silenced MDA-MB-231 and MCF-10A cells were previously established in our lab (27 (link)). Transfected, parental MDA-MB-231 and MCF-7 cells were cultured in DMEM (Biological Industries, Beit Haemek, Israel) containing 10% fetal bovine serum (Biological Industries) and 1% penicillin/streptomycin (Beyotime, Haimen, Jiangsu, China). Transfected and parental MCF-10A cells were cultured in DMEM/F12 (Gibco, Thermo Fisher Scientific; San Jose, CA, USA) supplemented with 5% horse serum (Thermo Fisher Scientific), hydrocortisone, epidermal growth factor (EGF, Peprotech; Rocky Hill, NJ, USA), cholera toxin, recombinant human insulin (Sigma-Aldrich; St. Louis, MO, USA), and 1% penicillin/streptomycin. All cells were cultured at 37°C in 5% CO2 atmosphere.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!